Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LIM zinc finger domain containing 2 (LIMS2) is an adapter protein found in the cytoplasm where it forms part of a complex that links beta-integrins to the actin cytoskeleton and bridges these complexes to cell surface receptor tyrosine kinases and growth factor receptors[1][2][6][7][8]. LIMS2 is important for modulating cell shape, cell spreading, and migration by organizing protein-protein interactions at focal adhesions, which are cellular structures that mediate connection between the cell and extracellular matrix. The protein contains five LIM domains, each forming two zinc fingers, which mediate these interactions. Pathogenic mutations in LIMS2 are associated with a rare form of autosomal recessive muscular dystrophy with cardiomyopathy and triangular tongue, and emerging studies support a potential role in cancer biology as a suppressor of colon cancer cell migration[1][2][6][9]. No approved drugs or clinical biomarkers are currently described for LIMS2 as a direct therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LIM zinc finger domain containing 2 (LIMS2).